Latest / Making it in Manufacturing
The Relentless Mindset Behind Scaling a Drug Manufacturing Company | Philippe Clavel
Building a CDMO capable of taking therapies from early discovery to commercial supply requires more than scale. It requires scientific depth, operational discipline and a culture that embraces problems rather than avoids them.
This week on Making It In Manufacturing, Harry Sloan sat down with Philippe Clavel, CEO of Curapath, bringing decades of experience across pharmaceutical manufacturing, leadership and CDMO strategy.
In this episode, Philippe Clavel covers:
• The evolution of CuraPath from a university spin-off focused on polymer science to a drug delivery CDMO serving biotech and large…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.